Trademark Overview
On Tuesday, June 4, 2024, a trademark application was filed for IBDIQ with the United States Patent and Trademark Office. The USPTO has given the IBDIQ trademark a serial number of 98584115. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, June 4, 2024. This trademark is owned by Takeda Pharmaceuticals U.S.A., Inc.. The IBDIQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about Inflammatory Bowel Disease (IBD) and pharmaceutical treatment thereof.